The role of metformin in the modern strategy of treatment and prevention of type 2 diabetes mellitus
Metformin is a major antihyperglycemic agent used for the treatment of DM2. Analysis of the mechanism of its action is presented. Cardioprotectiveand anticancer activities of metformin are discussed. Results of multicentre studied of metformin are described.
Enregistré dans:
Auteur principal: | Olga Mikhailovna Smirnova |
---|---|
Format: | article |
Langue: | EN RU |
Publié: |
Endocrinology Research Centre
2010
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4954f55e23f945f3bfcbe13e9a160e48 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
par: Alexander Sergeevich Ametov, et autres
Publié: (2010) -
Metformin and cancer mortality
par: Lev Mikhaylovich Bershteyn
Publié: (2010) -
Effects of metformin on body weight in patients with type 2 diabetes mellitus,receiving insulin analogue treatment
par: Tatiana Ivanovna Romantsova, et autres
Publié: (2013) -
Phenotypic and genetic characteristics of patients with type 2 diabetes with different responses to metformin therapy in Novosibirsk region
par: Irina A. Bondar, et autres
Publié: (2016) -
Multidimensional effects of metformin in patients with type 2 diabetes
par: Lyudmila A. Ruyatkina, et autres
Publié: (2017)